Colchicine is an anti-inflammatory medication used to treat gout, pericarditis, familial Mediterranean fever, and, as of 2023, cardiovascular disease prevention. It works differently from typical painkillers, targeting the inflammatory process itself rather than blocking pain signals. That broad mechanism is why it shows up in treatment plans for conditions that seem unrelated on the surface.
How Colchicine Works
Colchicine interrupts inflammation at the cellular level by binding to proteins called tubulins, which are the building blocks of tiny structural fibers inside cells. These fibers, called microtubules, act like internal scaffolding that immune cells need to move, communicate, and attack. When colchicine locks onto tubulin, it prevents that scaffolding from assembling properly.
The practical result: white blood cells (particularly neutrophils, the first responders to inflammation) can’t travel to the site of irritation as easily, can’t stick to blood vessel walls, and can’t release the chemical signals that amplify swelling and pain. Colchicine also blocks a key part of the immune system’s alarm pathway, preventing cells from releasing powerful inflammatory molecules. At low doses it slows the inflammatory response; at higher doses it can dismantle it more aggressively.
Gout Flares and Prevention
Gout is the condition most closely associated with colchicine. During a gout flare, uric acid crystals in a joint trigger an intense inflammatory reaction. Colchicine works by stopping neutrophils from swarming those crystals and releasing the chemicals that cause swelling, redness, and severe pain.
For an acute flare, the standard approach is to take it at the very first sign of symptoms. Timing matters: the earlier you take it, the better it works. If you wait more than 24 to 36 hours into a flare, the benefit drops significantly. After treating an acute flare, you typically wait at least three days before taking another treatment dose.
Colchicine is also used long-term at a lower daily dose to prevent flares from happening in the first place. This is especially common when someone is starting a uric acid-lowering medication, which can paradoxically trigger flares during the adjustment period. Prevention doses are roughly half the amount used for an acute attack.
Pericarditis
Pericarditis is inflammation of the thin sac surrounding the heart. It causes sharp chest pain that often worsens with breathing or lying down. The condition frequently comes back after the first episode, and preventing recurrence is where colchicine has made the biggest difference.
A major randomized trial published in the New England Journal of Medicine found that adding colchicine to standard anti-inflammatory treatment (aspirin or ibuprofen) cut the rate of recurrent or persistent pericarditis nearly in half. In the colchicine group, about 17% had a recurrence, compared to nearly 38% in the placebo group. That translates to a number needed to treat of just four, meaning for every four patients given colchicine, one was spared a recurrence. The treatment also reduced lingering symptoms at 72 hours and lowered hospitalization rates.
For pericarditis, the typical course runs about three months. European cardiology guidelines now recommend colchicine as a first-line treatment for recurrent pericarditis, and the evidence supports starting it during the first episode as well to reduce the chance of it coming back.
Familial Mediterranean Fever
Familial Mediterranean fever (FMF) is a genetic condition causing recurring episodes of fever and painful inflammation in the abdomen, chest, or joints. These attacks can last one to three days and, over time, lead to a serious complication called amyloidosis, where abnormal proteins build up in organs. Colchicine is the cornerstone treatment for FMF. Taken daily, it reduces both the frequency and severity of attacks and protects against amyloidosis. Most people with FMF take colchicine for life.
Cardiovascular Disease Prevention
In June 2023, the FDA approved low-dose colchicine (0.5 mg daily, sold as Lodoco) as the first anti-inflammatory therapy specifically for reducing the risk of heart attacks, strokes, and other events caused by atherosclerosis. This was a landmark decision because it validated the idea that chronic, low-grade inflammation in artery walls plays a direct role in cardiovascular events, not just cholesterol levels alone.
The cardiovascular dose is notably lower than what’s used for gout or pericarditis. All the major heart trials used 0.5 mg once daily, and the approval was based on consistent evidence that this small dose reduced the rate of major cardiovascular events in people who already had established heart disease. It’s meant to be taken alongside standard therapies like statins and blood pressure medications, not as a replacement.
Other Inflammatory Conditions
Colchicine is used off-label for several other conditions driven by similar inflammatory pathways. Calcium pyrophosphate deposition disease (sometimes called pseudogout) involves crystal deposits in joints much like gout, and colchicine can help manage and prevent flares. It’s also used in Behçet’s disease, a condition that causes recurring mouth sores, genital ulcers, and eye inflammation. These uses aren’t FDA-approved but are supported by clinical experience and smaller studies.
Side Effects and Safety
Colchicine has a narrow therapeutic window, meaning the gap between an effective dose and a toxic one is relatively small. The most common side effects are gastrointestinal: diarrhea, nausea, vomiting, and abdominal cramping. These are so predictable that they actually serve as an early warning system. If GI symptoms appear, it’s a signal that the dose may need to be lowered before more serious problems develop.
At therapeutic doses, these digestive side effects are usually manageable and go away when the dose is reduced or the drug is stopped. Overdose, however, is a different story entirely. Toxic doses can cause bone marrow suppression, kidney failure, muscle breakdown, seizures, and cardiovascular collapse. The estimated toxic threshold is roughly seven times the effective dose per kilogram of body weight, and lethal doses are approximately 50 times higher, but individual variation and drug interactions can shrink that margin considerably.
Drug Interactions to Know About
The most dangerous colchicine interactions involve medications that slow how your body breaks down and eliminates the drug. Colchicine is processed through two pathways in the body, and drugs that block either one can cause colchicine to accumulate to toxic levels even at normal doses.
The highest-risk medications include certain antibiotics (clarithromycin, erythromycin), antifungals (ketoconazole, itraconazole), the HIV drug ritonavir, and heart medications like diltiazem and verapamil. The immunosuppressant cyclosporine is another major concern, with fatal cases of severe muscle breakdown reported when combined with colchicine. Clarithromycin, a commonly prescribed antibiotic for respiratory and stomach infections, is one of the most frequently cited culprits in colchicine toxicity cases. Even a single combined dose can raise the risk.
If you’re taking colchicine regularly, any new prescription warrants a check for interactions. People with significant kidney or liver problems also need adjusted doses, since both organs play a role in clearing colchicine from the body.